MD or equivalent medical degree required. Minimum of 6+ years clinical development experience. Significant experience in immunology and/or inflammation indications. Experience with antibody therapeutics preferred. Demonstrated success in designing, executing, and interpreting IBD clinical trials. Prior experience with regulatory submissions and interactions. Deep understanding of GCP, clinical trial design, biostatistics, and global regulatory expectations. Excellent communication and presentation skills. Strategic mindset combined with strong operational execution capabilities. Proven ability to thrive in a fast-paced, entrepreneurial environment.